# Individualized Treatments in Adults With Relapsed/Refractory Cancers

> **NCT06024603** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Case Comprehensive Cancer Center** · enrollment: 36 (actual)

## Conditions studied

- Refractory Cancer
- Relapsed Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Drug Sensitivity Test (DST)

## Key facts

- **NCT ID:** NCT06024603
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-20
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06024603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06024603, "Individualized Treatments in Adults With Relapsed/Refractory Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06024603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*